Frontiers | Case report: Dual dabrafenib and trametinib therapy for treating BRAF V600E mutated lung adenocarcinoma with BRCA2 germline mutation post multiline progression User WalkingHorse, in the LungCancerSupport subreddit, 08 May 2024